Travere Therapeutics, Inc. (NASDAQ:TVTX) to Post FY2026 Earnings of $2.81 Per Share, Wedbush Forecasts
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Equities researchers at Wedbush upped their FY2026 earnings per share estimates for Travere Therapeutics in a report released on Wednesday, October 9th. Wedbush analyst L. Chico now forecasts that the company will post earnings of $2.81 per share for the year, up from their previous estimate of […]
11 Oct 07:21 · The Cerbat Gem